FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026162830> ?p ?o ?g. }

• W2026162830 endingPage "27" @default.
• W2026162830 startingPage "15" @default.
• W2026162830 abstract "Double-stranded RNA is produced during virus replication and, together with the viral antigen, is responsible for inducing host antivirus immunity. The hepatitis C virus (HCV) non-structural protein-3 (NS3) has been implicated in the immune evasion of HCV, and is one of the prime targets for inducing immunity against HCV infection. Mice were immunized with recombinant NS3 protein (rNS3) and poly (I:C) emulsified in Montanide ISA 720 (M720). Cytokine production was assayed by enzyme-linked immunospot assay, and CD4(+) IFN-gamma(+) T helper (Th) cells or CD8(+) IFN-gamma(+) cytotoxic T lymphocytes were detected by flow cytometry. Anti-NS3 titre and immunoglobulin G2a (IgG2a) and IgG1 levels were monitored by enzyme-linked immunosorbent assay. Administration of rNS3 formulated in poly (I:C) and M720 induced anti-NS3 titres with a predominantly IgG2a isotype comparable to those induced by rNS3 in CpG-ODN and M720. The cytokine profiles showed that this formulation induced a Th1-biased immune response with several-fold more interferon-gamma (IFN-gamma)-producing cells than interleukin-4-producing cells. In contrast, rNS3 in M720 induced a Th2-biased immune response. The frequency of IFN-gamma-producing CD4(+) and CD8(+) cells induced by rNS3 in poly (I:C) and M720 was significantly higher than that induced by rNS3, rNS3 in M720, or rNS3 in poly (I:C), and was comparable to that induced by rNS3 in CpG-ODN with M720. The antigen-specific CD8(+) T-cell immune response persisted for up to 7 months after immunization. In conclusion, poly (I:C) with rNS3 in M720 can elicit a strong and persistent Th1-biased immune response and a cytotoxic T-lymphocyte response through cross-priming in mice. This study highlighted a promising formulation for inducing an efficient cellular immune response against HCV that has potential for HCV vaccine development." @default.
• W2026162830 created "2016-06-24" @default.
• W2026162830 creator A5011221249 @default.
• W2026162830 creator A5023744516 @default.
• W2026162830 creator A5028196606 @default.
• W2026162830 creator A5036426806 @default.
• W2026162830 creator A5069191697 @default.
• W2026162830 creator A5078204891 @default.
• W2026162830 creator A5089141180 @default.
• W2026162830 date "2007-04-23" @default.
• W2026162830 modified "2023-10-15" @default.
• W2026162830 title "Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA" @default.
• W2026162830 cites W1506811134 @default.
• W2026162830 cites W1964872907 @default.
• W2026162830 cites W1966256870 @default.
• W2026162830 cites W1967117573 @default.
• W2026162830 cites W1986019318 @default.
• W2026162830 cites W1986127081 @default.
• W2026162830 cites W2000952771 @default.
• W2026162830 cites W2004829503 @default.
• W2026162830 cites W2009802110 @default.
• W2026162830 cites W2013601771 @default.
• W2026162830 cites W2016525911 @default.
• W2026162830 cites W2017462823 @default.
• W2026162830 cites W2020473253 @default.
• W2026162830 cites W2021158198 @default.
• W2026162830 cites W2031112014 @default.
• W2026162830 cites W2032555249 @default.
• W2026162830 cites W2037368492 @default.
• W2026162830 cites W2047129511 @default.
• W2026162830 cites W2049115723 @default.
• W2026162830 cites W2054250357 @default.
• W2026162830 cites W2063887342 @default.
• W2026162830 cites W2064229941 @default.
• W2026162830 cites W2069390604 @default.
• W2026162830 cites W2074140053 @default.
• W2026162830 cites W2076361525 @default.
• W2026162830 cites W2078407720 @default.
• W2026162830 cites W2080254549 @default.
• W2026162830 cites W2083529547 @default.
• W2026162830 cites W2086522606 @default.
• W2026162830 cites W2086882580 @default.
• W2026162830 cites W2087747665 @default.
• W2026162830 cites W2087961202 @default.
• W2026162830 cites W2090698640 @default.
• W2026162830 cites W2094254049 @default.
• W2026162830 cites W2098676417 @default.
• W2026162830 cites W2102452709 @default.
• W2026162830 cites W2117761826 @default.
• W2026162830 cites W2121016297 @default.
• W2026162830 cites W2124473438 @default.
• W2026162830 cites W2135644179 @default.
• W2026162830 cites W2141137217 @default.
• W2026162830 cites W2148214390 @default.
• W2026162830 cites W2148387062 @default.
• W2026162830 cites W2153145162 @default.
• W2026162830 cites W2161771158 @default.
• W2026162830 cites W2164489022 @default.
• W2026162830 cites W2167286967 @default.
• W2026162830 cites W2170105187 @default.
• W2026162830 cites W2172466148 @default.
• W2026162830 cites W2395577818 @default.
• W2026162830 cites W2466462007 @default.
• W2026162830 cites W2792087431 @default.
• W2026162830 cites W4245774772 @default.
• W2026162830 cites W4246809453 @default.
• W2026162830 cites W63754614 @default.
• W2026162830 doi "https://doi.org/10.1111/j.1365-2567.2007.02607.x" @default.
• W2026162830 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2265985" @default.
• W2026162830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17451465" @default.
• W2026162830 hasPublicationYear "2007" @default.
• W2026162830 type Work @default.
• W2026162830 sameAs 2026162830 @default.
• W2026162830 citedByCount "33" @default.
• W2026162830 countsByYear W20261628302012 @default.
• W2026162830 countsByYear W20261628302013 @default.
• W2026162830 countsByYear W20261628302015 @default.
• W2026162830 countsByYear W20261628302016 @default.
• W2026162830 countsByYear W20261628302018 @default.
• W2026162830 countsByYear W20261628302020 @default.
• W2026162830 countsByYear W20261628302021 @default.
• W2026162830 countsByYear W20261628302022 @default.
• W2026162830 crossrefType "journal-article" @default.
• W2026162830 hasAuthorship W2026162830A5011221249 @default.
• W2026162830 hasAuthorship W2026162830A5023744516 @default.
• W2026162830 hasAuthorship W2026162830A5028196606 @default.
• W2026162830 hasAuthorship W2026162830A5036426806 @default.
• W2026162830 hasAuthorship W2026162830A5069191697 @default.
• W2026162830 hasAuthorship W2026162830A5078204891 @default.
• W2026162830 hasAuthorship W2026162830A5089141180 @default.
• W2026162830 hasBestOaLocation W20261628301 @default.
• W2026162830 hasConcept C132379496 @default.
• W2026162830 hasConcept C147483822 @default.
• W2026162830 hasConcept C153911025 @default.
• W2026162830 hasConcept C154317977 @default.
• W2026162830 hasConcept C159047783 @default.
• W2026162830 hasConcept C159654299 @default.
• W2026162830 hasConcept C167672396 @default.

• next